LHC Group
LHC Group is top performer in latest CMS Star quality and patient satisfaction scores
June 11, 2019 06:30 ET | LHC Group
LAFAYETTE, La., June 11, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc.’s (NASDAQ: LHCG) most recent Centers for Medicare and Medicaid Services (CMS) Five-Star Quality Rating System results showed an...
LHC Group
LHC Group to Present at Two Healthcare Conferences in June
May 30, 2019 06:30 ET | LHC Group
LAFAYETTE, La., May 30, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the Jefferies 2019 Healthcare Conference in New York and the William...
jpg.jpg
Incysus Therapeutics to Present at Jefferies 2019 Global Healthcare Conference
May 22, 2019 07:00 ET | Incysus Therapeutics, Inc.
NEW YORK, May 22, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
logo_new.jpg
ObsEva SA to Participate in Upcoming Investor Conferences
May 16, 2019 01:00 ET | ObsEva SA
Geneva, Switzerland and Boston, MA – May 16, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...
Abeona Therapeutics.jpg
Abeona Therapeutics Announces Participation in Upcoming Investor Conferences
May 07, 2019 16:15 ET | Abeona Therapeutics Inc.
NEW YORK and CLEVELAND, May 07, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced its participation in the...
logo_new.jpg
ObsEva SA to Participate in Upcoming Investor Conferences
February 22, 2019 01:00 ET | ObsEva SA
Geneva, Switzerland and Boston, MA – February 22, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...
logo.png
Corbus Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
January 30, 2019 07:30 ET | Corbus Pharmaceuticals Holdings, Inc.
Norwood, MA, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company), a clinical stage drug development company with the industry’s leading...
logo.png
Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
January 25, 2019 09:01 ET | Corbus Pharmaceuticals Holdings, Inc.
Norwood, MA, Jan. 25, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company), a clinical stage drug development company with the industry’s leading...
LHC Group
LHC Group’s latest CMS Star ratings continue to set the standard for high quality and patient satisfaction
November 27, 2018 07:00 ET | LHC Group
LAFAYETTE, La., Nov. 27, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) continues to produce industry-leading quality and patient satisfaction scores, beating national averages and posting...
rosehill-logo-final-high.jpg
Rosehill Resources Inc. to Present at Jefferies 2018 Global Energy Conference
November 20, 2018 16:30 ET | Rosehill Resources Inc.
HOUSTON, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Rosehill Resources Inc. (“Rosehill” or the “Company”) (NASDAQ: ROSE, ROSEW, ROSEU) today announced that it will be presenting and hosting one-on-one...